Empleados: 11 (2023.0)Categoría jurídica: 5485Tamaño: PMEFecha de creación: 2010-08-01 (15 años)Estado: ActivaSector de actividad: Commerce de détail de produits pharmaceutiques en magasin spécialiséUbicación: MONTEREAU-FAULT-YONNE (77130), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE KREHER-PEYROUX : revenue, balance sheet and financial ratios
PHARMACIE KREHER-PEYROUX is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTEREAU-FAULT-YONNE (77130),
this company of category PME
shows in 2025 a net income positive of 76 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2025, PHARMACIE KREHER-PEYROUX generates positive net income of 76 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 37 k€ -> 76 k€.
Resultado neto (2025)
?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios
75 978 €
Chargement du compte de résultat...
Cuenta de resultados
Poste
Importe
% CA
Evolución
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Mostrar :
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Activo
Chargement des données...
Poste
Bruto
Amort.
Neto
%
Evolución
Données de bilan actif non disponibles pour cette entreprise
Pasivo
Chargement des données...
Poste
Ejercicio
%
Evolución
Données de bilan passif non disponibles pour cette entreprise
Ratios de solvencia y endeudamiento
The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory.
Ratio de endeudamiento (2025)
?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible 50-100% : Moderado > 100% : Alto
115.068%
Autonomía financiera (2025)
?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Evolución de indicadores de solvencia PHARMACIE KREHER-PEYROUX
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Indicador
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ratio de endeudamiento
87.47
75.243
71.705
62.391
84.199
268.008
144.756
125.013
133.732
115.068
Autonomía financiera
46.802
50.244
51.49
54.415
48.466
23.922
35.768
37.934
36.727
39.785
Capacidad de reembolso
None
None
None
None
None
None
None
None
None
None
Flujo de caja / Ingresos
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Positionnement sectoriel
Debt ratio
115.072025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average+7 pts durante 3 años
In 2025, the debt ratio of PHARMACIE KREHER-PEYROUX (115.07) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.78%2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Average
In 2025, the financial autonomy of PHARMACIE KREHER-PEYROUX (39.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Ratios de liquidez
The liquidity ratio (= Current assets / Current liabilities) stands at 117.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Ratio de liquidez (2025)
?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno 1-1.5 : Correcto < 1 : Risque de liquidité
117.015
Evolución de indicadores de liquidez PHARMACIE KREHER-PEYROUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicador
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ratio de liquidez
87.101
92.414
102.2
91.923
178.289
244.203
204.524
168.383
137.208
117.015
Cobertura de intereses
None
None
None
None
None
None
None
None
None
None
Positionnement sectoriel
Liquidity ratio
117.022025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Watch-18 pts durante 3 años
In 2025, the liquidity ratio of PHARMACIE KREHER-PEYROUX (117.02) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positionnement de PHARMACIE KREHER-PEYROUX dans son secteur
Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Estimación de valoración
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE KREHER-PEYROUX is estimated at
1 206 919 €
(range 819 021€ - 1 893 822€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
819k€1206k€1893k€
1 206 919 €Range: 819 021€ - 1 893 822€
NAF 5 année 2025
Valuation method used
Net Income Multiple
75 978 €
×
15.9x
=1 206 920 €
Range: 819 021€ - 1 893 823€
Only this financial indicator is available for this company.
Evolución de la valoración
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE KREHER-PEYROUX with other companies in the same sector:
Frequently asked questions about PHARMACIE KREHER-PEYROUX
What is the revenue of PHARMACIE KREHER-PEYROUX ?
The revenue of PHARMACIE KREHER-PEYROUX is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE KREHER-PEYROUX profitable?
Yes, PHARMACIE KREHER-PEYROUX generated a net profit of 76 k€ in 2025.
Where is the headquarters of PHARMACIE KREHER-PEYROUX ?
The headquarters of PHARMACIE KREHER-PEYROUX is located in MONTEREAU-FAULT-YONNE (77130), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE KREHER-PEYROUX ?
The tax return of PHARMACIE KREHER-PEYROUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE KREHER-PEYROUX operate?
PHARMACIE KREHER-PEYROUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Gire su teléfono en modo horizontal para ver el gráfico